IMPORTANT INFORMATION: MOUNJARO
From Monday 23rd June 2025 the national roll out of tirzepatide (Brand name Mounjaro) for the management of obesity begins.
We anticipate a lot of demand for this BUT there is a nationally set roll out programme which limits eligibility for many years.
Every year additional patients will become eligible but for the first year only a VERY SMALL number of patients will meet the criteria.
The eligibility for this year is ONLY if you have a BMI of 40 or over AND have four or more of the following health conditions:
Type 2 Diabetes
High Blood Pressure
High Cholesterol
Sleep apnoea
Cardiovascular disease
AND a clinician considers it appropriate treatment.
The vast majority of our patients do not currently fit this criteria and if you don’t fit the criteria we cannot offer you this medication this year. We are not allowed to prescribe outside of the set roll out programme.
We will publicise the changes each year – but note it is a 10 year roll out programme.
In the meantime we recommend you book to see our health coaches – who have access to other resources and opportunities to help you and have had great success helping with lifestyle changes and weight loss.